FDA Inspection
Avista Pharma Solutions, Inc. dba CambrexFDA Inspection 1113974 - Avista Pharma Solutions, Inc. dba Cambrex - December 18, 2019
Discuss this record with AI
Record Details
This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on December 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 43a50e53-b23a-4132-b1c6-e57509860e23
Violation Codes2
21 CFR 211.22(d)21 CFR 211.67(a)
Full citation text and observation details available on the Dashboard.